Zobrazeno 1 - 10
of 29
pro vyhledávání: '"James O. O'Neill"'
Autor:
Alan Carr, Alison McGrann, Veronica O’Doherty, Vincent Maher, James O. O’Neill, Ian Graham, Siobhan Dinan
Publikováno v:
Mindfulness. 6:405-416
This study evaluated the effectiveness of an eight-session mindfulness-based cognitive therapy (MBCT) group intervention programme for treating depression in coronary heart disease (CHD) patients. Thirty-two depressed CHD patients were assigned to an
Autor:
Sandrine Brette, Lisa Naditch-Brûlé, Marnix Goethals, P. Gabriel Steg, O. Zharinov, Habib Gamra, James O. O'Neill, Chern-En Chiang
Publikováno v:
Europace. 15:1733-1740
Aims International atrial fibrillation (AF) guidelines have defined optimal drugs for patients with various underlying diseases, but the extent to which real-life practice complies with these guidelines is unknown. This study aimed to evaluate the ap
Autor:
Frederick Van Lente, Randall C. Starling, David M. Weinstein, David O. Taylor, Mazen Hanna, W.H. Wilson Tang, Sey M. Lau, Emil P. Paganini, James O. O'Neill, Boon Wee Teo
Publikováno v:
Congestive Heart Failure. 18:54-63
Compared with conventional diuretic (CD) therapy, ultrafiltration (UF) is associated with greater weight loss and fewer re-hospitalizations in patients admitted with decompensated heart failure (HF). Concerns have been raised regarding its safety and
Implantable cardioverter-defibrillators in a heart transplant population: A single-center experience
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 35(5)
The use of implantable cardiac defibrillators (ICDs) for the prevention of sudden cardiac death (SCD) in patients with ischemic and non-ischemic cardiomyopathies is well described. However, little is known about the role these devices might play in t
Autor:
James B. Young, Bruce W. Lytle, Randall C. Starling, James O. O'Neill, Nicholas G. Smedira, Patrick M. McCarthy, Jose L. Navia, Nancy M. Albert
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 30:753-759
Objective: Left ventricular reconstruction (LVR) is performed to improve the morphologic structure and function of the heart in patients with heart failure. This procedure has been performed at the Cleveland Clinic Foundation since 1997. We assessed
Publikováno v:
The Journal of Heart and Lung Transplantation. 25:1186-1191
Background Malignancy after organ transplantation has been described as the "price of immunotherapy." Evolving strategies aimed at effective immunosuppression could have differing effects on the likelihood of developing malignancy. We analyzed data f
Autor:
James O. O'Neill, Yaariv Khaykin, Nancy M. Albert, James B. Young, Patrick M. McCarthy, Mina K. Chung, Melanie D. Hail, Randall C. Starling, Nicholas G. Smedira
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 130:1250-1256
Objective Left ventricular reconstruction is performed in patients with ischemic cardiomyopathy and akinetic or dyskinetic left ventricular regions. These patients may remain at risk for malignant ventricular arrhythmias and hence may benefit from pr
Autor:
Kenneth Ng, Richard W. Troughton, James O. O'Neill, Corinne Bott-Silverman, James B. Young, Randall C. Starling, Andrew T. Mcrae
Publikováno v:
American Heart Journal. 149:363-369
Background We sought to assess the utility of serial BNP measurements in patients with severe heart failure and attempted to correlate values with invasively derived data. Methods In a retrospective study, we analyzed serial BNP levels in patients re
Autor:
Richard C. Brunken, Tiffany Buda, Katherine J. Hoercher, James O. O'Neill, Patrick M. McCarthy, Randall C. Starling, James B. Young
Publikováno v:
Journal of Cardiac Failure. 10:244-249
Background The abnormalities in dilated cardiomyopathy (DCM) are generally considered diffuse and to affect the left ventricle in a global manner. However, regional wall motion abnormalities and metabolic defects may also occur to varying, but unclea
Publikováno v:
Journal of Cardiac Failure. 11:9-11
Background Ephedra is a sympathomimetic commonly used for the purposes of athletic performance enhancement and weight loss. It is known to be associated with gastrointestinal and psychiatric manifestations. We report here on 6 cases of dilated cardio